Elizabeth, NJ, United States of America

Ling Pang


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2002-2005

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Inventor Ling Pang

Introduction

Ling Pang is an accomplished inventor based in Elizabeth, NJ (US). He has made significant contributions to the field of medical science, particularly in the area of leukotriene receptors. With a total of 2 patents to his name, his work has the potential to impact various medical conditions.

Latest Patents

Ling Pang's latest patents focus on the development of isolated mammalian leukotriene receptors. The inventions provide isolated or recombinant nucleic acids and recombinant vectors encoding these receptors. Additionally, they include host cells that comprise the nucleic acids and vectors, along with methods for producing the receptor using these host cells. The inventions also offer antibodies and antigen-binding fragments that specifically bind to the receptor, which can be useful for treating medical conditions caused or mediated by leukotriene. Furthermore, screening methods for identifying specific agonists and antagonists of the mammalian leukotriene receptor are also included in his patents.

Career Highlights

Ling Pang is currently associated with Schering Corporation, where he continues to innovate and contribute to advancements in medical research. His work has garnered attention for its potential applications in treating various health issues.

Collaborations

Ling has collaborated with notable coworkers, including Suke Wang and Thomas M Laz, who have contributed to his research endeavors.

Conclusion

Ling Pang's innovative work in the field of leukotriene receptors showcases his dedication to advancing medical science. His patents reflect a commitment to developing solutions for medical conditions, highlighting the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…